Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
about
Pharmacological interventions for alcoholic liver disease (alcohol-related liver disease): a network meta-analysisCurrent Management of Alcoholic Hepatitis and Future TherapiesNew treatment options for alcoholic hepatitisManaging alcoholic liver diseaseUpdate on Alcoholic HepatitisZebrafish: an important tool for liver disease researchAlcoholic liver disease: pathogenesis, management, and novel targets for therapyHepatoprotective and anti-fibrotic functions of interleukin-22: therapeutic potential for the treatment of alcoholic liver diseaseAlcoholic hepatitis: a comprehensive review of pathogenesis and treatmentCritical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical TrialsGlutamate Transporter GLT-1 as a Therapeutic Target for Substance Use DisordersEmerging concepts in alcoholic hepatitisAcute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.New drug targets for alcoholic liver disease.Combination therapy: New hope for alcoholic hepatitis?New therapeutic targets in alcoholic hepatitis.Alcoholic hepatitis and concomitant hepatitis C virus infection.Pharmacotherapy for alcoholic patients with alcoholic liver diseaseAlcoholic liver disease: treatmentAlcoholic hepatitis: current challenges and future directions.Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.N-acetylcysteine inhibits the up-regulation of mitochondrial biogenesis genes in livers from rats fed ethanol chronically.Cell death and cell death responses in liver disease: mechanisms and clinical relevanceDiagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.Advances in alcoholic liver disease: An update on alcoholic hepatitisMolecular targets in the treatment of alcoholic hepatitis.Management of alcoholic hepatitis: Current concepts.Doubly blind: a systematic review of gender in randomised controlled trials.Alcoholic Hepatitis: Steroids vs. PentoxifyllinePathogenesis and Management of Alcoholic Liver Disease.KASL clinical practice guidelines: management of alcoholic liver diseaseTrends in the management and burden of alcoholic liver disease.Practical Concerns and Controversies in the Management of Alcoholic Hepatitis.Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.Infections in severe alcoholic hepatitis.Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USAAlcoholic hepatitis: diagnosis and management in 2012.
P2860
Q24186882-544A8BEC-072D-4832-9D3A-3F61010CC1D7Q26746544-5526505B-E42C-4306-B748-B7C3EB52AB35Q26751402-4359D046-9223-48EA-BEFF-80D74E861FDCQ26777480-0562161F-7B62-4C77-8241-43F5BB1D4BF6Q26779121-4DB322EF-C3C0-4822-93C3-B407FC10B61FQ26796338-054FA04F-E8ED-4C9B-97AC-A50540908502Q26861620-D9F61D7A-EF6C-4E62-BB63-B6315B1FC6F1Q27027380-A47C6C72-DA00-4A56-92F4-92A660CF35A0Q27027418-61B6855F-D63D-4B65-BF04-AAF7523FE2D4Q28073542-AFA9CAC2-1D69-478A-A0E8-2F25C77BF7F9Q28081726-1C8DCC11-4BDB-4F07-BE8F-A4FB12FFC04FQ30234425-87296406-131B-4EA2-BE2F-04964B03243BQ30234560-31AAE156-1AE1-429D-A4E5-1ADE685D1B90Q33587538-58AA90DE-A981-4D3B-B52E-61003D06F930Q33746508-DFB02745-5138-4B2F-AF1B-886B99C0D19FQ33746519-5EECE205-FE0D-4E99-840A-2D711ED06E0AQ33757267-DE42B243-45CF-473B-B29A-8351305AC8DAQ34168404-AC7D8C08-6540-44BE-9682-53C074D97B29Q34223054-97EEB477-B105-41C1-8AD7-0DCB4592630AQ34255479-A7C2C447-A110-4729-ADAC-71C55260D569Q34354286-27F3DB52-F3BF-4FBB-B26E-D163945651DCQ34404386-80A4A665-1F3F-4F6D-9856-08FF184FAE8FQ34941244-D23410AF-408E-4C4D-A8ED-3EA7E929B056Q35938040-419F528C-F7AD-46F7-920B-CE6FA0C3F530Q36038296-C2C39DE8-9C1C-4071-977E-58EB09190D37Q36269638-DC853DCA-8443-4D2A-9472-58C64FA15491Q36351877-8119BDDA-FDBC-4DEE-9212-08F48567216AQ36561560-494AA63D-ACB0-41D5-9A35-2B7A5A3EFCB8Q36805845-CF8D4DB8-DA63-44DF-AB72-6E659A2E6B17Q36899751-105B2C81-0886-4D17-8958-2812504D8077Q37011836-F1F0B827-BF0F-401B-85D7-CBEAEBE481EEQ37229858-1C6BFAB5-5E4C-4DCB-A279-4EB6895FFC0AQ37237035-2018DBCB-0226-4EA3-A6C8-4ADBA2D1267DQ37421502-49368071-9CF3-4260-9DD2-57A9CD06E0E5Q37424578-C4ABB012-6947-4A2F-B31D-9C68F39ED73BQ37619758-F3A1B3FA-7DDA-4690-A77A-D6D77008B0B0Q37657099-661CAD54-708A-413F-8BEE-8800CE2E71C0Q37696026-FD371D44-9539-4D17-A2E2-8E44FD5D8EFDQ37728503-FF615DDF-3CEC-411D-8718-6546B9275B68Q38067131-73C01DA1-C002-46BC-BC37-8C0E8E28F7BA
P2860
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@ast
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@en
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@nl
type
label
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@ast
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@en
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@nl
prefLabel
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@ast
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@en
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@nl
P2093
P356
P1476
Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
@en
P2093
AAH-NAC Study Group
Abdeslam Bental
Blaise Tramier
Brigitte Bernard-Chabert
Denis Chatelain
Eric Nguyen-Khac
François Dewaele
Hervé Tossou
Jean-Louis Dupas
Marie-Astrid Piquet
P304
P356
10.1056/NEJMOA1101214
P407
P577
2011-11-01T00:00:00Z